Collectively, the present study indicates that Sox8 downregulation inhibits the PI3K/AKT/mTOR signaling pathway and increases the level of autophagy in MSU-induced impairment of chondrocytes in vitro and in vivo, making Sox8 a potential treatment target for gout-induced osteoarthritis. This evidence concerns the gene AKT1 and gout.